Ana Catarina Silvais an Associate Professor with Habilitation in Pharmaceutical Technology and Pharmaceutical Biotechnology at the Faculty of Health Sciences, University Fernando Pessoa, Porto, Portugal. She is also a Senior Researcher at UCIBIO, Faculty of Pharmacy, University of Porto (FFUP), and a Researcher at FP-I3ID, FP-BHS, University Fernando Pessoa. Since 2025, she has been a member of the Board of the Northern Regional Section of the Portuguese Pharmaceutical Society. Her current research interests include lipid-based nanosystems for advanced drug delivery, particularly nose-to-brain and cutaneous delivery strategies, quality-by-design (QbD) approaches for formulation optimization, and the development of biopharmaceuticals and advanced therapy medicinal products (ATMPs). She holds a European PhD in Pharmaceutical Sciences, with a specialization in Pharmaceutical Technology, awarded by the University of Porto in 2012, and a degree in Pharmaceutical Sciences from the University Fernando Pessoa (2006). She is Principal Investigator of the UCIBIO/FFUP research group in the projects "Marie Waste Biorefinery: Bioactive Platforms for a Circular Cosmetic Industry" and "Shrimp4NanoCosmetics & New Nanotechnology-Based Cosmetic Products Obtained through Advanced Marine Biomass Extraction and Valorisation Technologies," and a researcher in additional funded R&D projects. Her scientific excellence has been recognized by inclusion in Stanford University&s World&s Top 2% Scientists list for 5 consecutive years (2021&2025). She is the author of more than 70 scientific publications in the fields of Pharmaceutical Technology and Pharmaceutical Biotechnology, including original research articles, review papers, books, book chapters, and edited special issues (Scopus h-index: 31).

She serves as an Editor of theInternational Journal of Biological Macromolecules(Elsevier) since January 2026 and is a member of the editorial boards of several international journals and book series, includingAdvances in Biochemical Engineering/Biotechnology(Springer),Chinese Chemical Letters(Elsevier),Dermatological Drug Delivery from Frontiers in Drug Delivery(Frontiers),Current Drug Metabolism(Bentham Science), andBiochemistry & Pharmacology: Open Access(Longdom). She regularly acts as a referee for international funding agencies and a wide range of peer-reviewed journals. She has extensive experience in the supervision of undergraduate, master&s, and doctoral students, particularly within nationally funded research projects. Her academic and research activity has been strongly focused on Pharmaceutical Biotechnology. She has edited and authored several book chapters in the Springer series Advances in Biochemical Engineering/Biotechnology, including the volumeCurrent Applications of Pharmaceutical Biotechnology, and is the author of the SpringerBriefBiotechnology for Pharmaceutical Sciences: Concepts and Applications, developed from her teaching activities.